P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY

ABSTRACT:

SUBMITTER: Zheng Z 

PROVIDER: S-EPMC10430982 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature